What’s more, the cleavage of GSDME and the release of LDH could be inhibited by Z-DEVD-FMK, a specific inhibitor of caspase3, meanwhile, cell viability is restored in 4f treated breast cancer cells after treating with Z-DEVD-FMK. Here, GSDME is linked to breast carcinoma.